HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oréal

This article was originally published in The Rose Sheet

Executive Summary

French company is evaluating Japanese cosmetics business Kanebo as a potential acquisition target, but declined to comment on specifics regarding its interest during Sept. 2 half year earnings presentation. "We are obliged to look at a dossier such as that one, as it is extremely rare...for a significant company in terms of market share in Japan to be up for sale," firm says. Japanese Industrial Revitalization Corporation currently is seeking a buyer for Kanebo. L'Oréal reported a 5.8% decline in net profit to $1.12 bil. (€1=$1.25), related to the deconsolidation of Sanofi-Synthelabo. Operating profit was flat at $1.39 bil. under new European accounting rules. L'Oréal reported first half sales in July (1"The Rose Sheet" July 18, 2005, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013326

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel